Advertisement
Canada markets open in 7 hours 57 minutes
  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CAD/USD

    0.7299
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    83.02
    +0.17 (+0.21%)
     
  • Bitcoin CAD

    91,042.13
    +627.62 (+0.69%)
     
  • CMC Crypto 200

    1,397.34
    -8.65 (-0.62%)
     
  • GOLD FUTURES

    2,325.20
    -21.20 (-0.90%)
     
  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • NASDAQ futures

    17,326.50
    -23.50 (-0.14%)
     
  • VOLATILITY

    16.94
    -1.77 (-9.46%)
     
  • FTSE

    8,023.87
    +128.02 (+1.62%)
     
  • NIKKEI 225

    37,550.79
    +112.18 (+0.30%)
     
  • CAD/EUR

    0.6849
    -0.0001 (-0.01%)
     

INVESTOR ALERT: Monteverde & Associates PC is Investigating the Announced Merger

NEW YORK, NY / ACCESSWIRE / May 11, 2019 / Juan Monteverde, founder and managing partner at Monteverde &Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • Zayo Group Holdings, Inc. ("Zayo" or the "Company") (ZAYO) in connection with the proposed acquisition of the Company by Digital Colony Partners LP and EQT Infrastructure IV Fund. Under the terms of the acquisition agreement, Zayo shareholders will receive $35.00 per share. Click here for more information: https://www.monteverdelaw.com/case/zayo-group-holdings-inc. It is free and there is no cost or obligation to you.

  • Aratana Therapeutics, Inc. (PETX) ("Aratana Therapeutics") regarding the sale of Aratana Therapeutics to Elanco Athens Inc. ("Elanco"). Under the terms of the proposed transaction, Aratana Therapeutics stockholders will receive 0.1481 shares of Elanco common stock plus one contingent value right ("CVR") representing the right to receive $0.25 in cash if a specified milestone is achieved, as set forth in the CVR Agreement, for each Aratana Therapeutics share they own. Click here for more information: https://www.monteverdelaw.com/case/aratana-therapeutics-inc. It is free and there is no cost or obligation to you.

  • HFF, Inc. ("HFF" or the "Company") (HF) related to the sale of the company to Jones Lang LaSalle Incorporated (JLL). Under the terms of the proposed transaction, each share of HFF common stock will receive $24.63 in cash and 0.1505 shares of JLL for each share of HFF they own. Click here for more information: https://www.monteverdelaw.com/case/hff-inc . It is free and there is no cost or obligation to you.



Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recoveredmillions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017 - 2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017 and 2018 Top Rated Lawyer.

ADVERTISEMENT

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.

MONTEVERDE & ASSOCIATES PC

The Empire State Building

350 Fifth Ave. Suite 4405

New York, NY 10118

United States of America

jmonteverde@monteverdelaw.com

Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/545080/INVESTOR-ALERT-Monteverde-Associates-PC-is-Investigating-the-Announced-Merger